Syapse: Fletcher Payne

Fletcher Payne has been appointed as CFO of precision oncology firm Syapse. Payne joins Syapse from Catalyst Biosciences, where he was CFO since January 2015. He has previously held senior financial positions at CytomX Therapeutics, Plexxikon, Rinat Neuroscience Corporation, Dynavax Technologies Corporation, Cell Genesys, Abgenix, Sun Microsystems, and IBM.